David B. Weiner
186Patents
16h-index
82Co-inventors
89Inventor score
Filing activity: May 21, 1982 → May 16, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5593972A | Genetic immunization | Emerging Cross-Sectional Technologies | 259 | Expired |
| US5739118A | Compositions and methods for delivery of genetic material | Emerging Cross-Sectional Technologies | 182 | Expired |
| US5817637A | Genetic immunization | Emerging Cross-Sectional Technologies | 136 | Expired |
| US5962428A | Compositions and methods for delivery of genetic material | Emerging Cross-Sectional Technologies | 127 | Expired |
| US5830876A | Genetic immunization | Emerging Cross-Sectional Technologies | 117 | Expired |
| US5981505A | Compositions and methods for delivery of genetic material | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5714316A | Chimeric envelope proteins for viral targeting | Chemistry; Metallurgy | 73 | Expired |
| US8178660B2 | Vaccines and immunotherapeutics using codon optimized IL-15 and methods for using the same | Human Necessities | 66 | Active |
| US8183352B2 | Attenuated vif DNA immunization cassettes for genetic vaccines | Emerging Cross-Sectional Technologies | 54 | Active |
| US5556744A | Methods and compositions for diagnosing and treating certain HIV infected patients | Emerging Cross-Sectional Technologies | 44 | Expired |
| US5837460A | Methods of identifying biologically active receptor-binding peptides | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5637677A | Biologically active compounds and methods of constructing and using the same | Chemistry; Metallurgy | 32 | Expired |
| US6733994B2 | Highly expressible genes | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5840300A | Methods and compositions comprising single chain recombinant antibodies | Human Necessities | 25 | Expired |
| US6468982B1 | Genetic immunization | Emerging Cross-Sectional Technologies | 18 | Expired |
| USD289609S | Liquid dispensing container | General | 18 | Expired |
| US6060587A | Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle | Physics | 16 | Expired |
| US6172201A | Cellular receptor for HIV-1 Vpr essential for G2/M phase | Physics | 15 | Expired |
| US6087486A | Nucleotide sequences encoding vpr receptor protein | Physics | 14 | Expired |
| US8202847B2 | Mutant human CD80 and compositions for and methods of making and using the same | Human Necessities | 11 | Active |
| US6348449B1 | Methods of inducing mucosal immunity | Chemistry; Metallurgy | 11 | Expired |
| US6228621A | Plasmids encoding immunogenic proteins and intracellular targeting sequences | Chemistry; Metallurgy | 11 | Expired |
| US9597388B2 | Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same | Chemistry; Metallurgy | 10 | Active |
| US9243041B2 | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US9272024B2 | Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same | Chemistry; Metallurgy | 9 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.